Dabrafenib Plus Trametinib Deemed Promising for BRAF-Mutant High-Grade Glioma
Dabrafenib plus trametinib can produce durable responses in pediatric patients with relapsed or refractory, BRAFV600-mutant high-grade glioma, a phase 2 trial suggests.
Diagnosis & Disease Information
Some Studies Support Use of Cannabis in Pediatric Cancer; More Research is Needed
There is some evidence to support the use of cannabis for symptom management in children with cancer, but there is a lack of evidence on the safety and efficacy of cannabinoids in this patient population, according to researchers.
Birth Weight Linked to Risk of Certain Pediatric Cancers
Birth weight may be associated with the risk of certain pediatric cancers, a new study suggests.
Increased Risk of Relapse for ALL Patients Living in Extreme Poverty
Among children receiving maintenance therapy for ALL, those living in extreme poverty had a nearly 2-fold greater risk of relapse than those not living in extreme poverty.
Fracking Linked to Childhood Lymphoma in New Study
Children who live near areas where fracking takes place appear to have an increased risk of lymphoma.
Score Can Predict Risk of Second Cancers in Pediatric Cancer Survivors
A polygenic risk score can predict the risk of second malignant neoplasms in pediatric cancer survivors who were treated with chemotherapy, according to researchers.
Body Composition Can Change During Chemo in Young Patients With Lymphoma, Rhabdomyosarcoma
Young patients with lymphoma or rhabdomyosarcoma may experience changes in body composition during chemotherapy, research suggests.
Overall Incidence of Pediatric Cancer in the US Increased From 2003 to 2019
The overall incidence of pediatric cancer in the United States increased from 2003 to 2019, researchers found.
Early-Life Cancer Diagnosis Can Have Lasting Psychological Impact
Children, adolescents, and young adults with cancer may experience a psychological burden lasting years after diagnosis, a review suggests.
As Cancer Drug Shortages Increase, Patients’ Lives Are at Stake
Oncology leaders testified before a House subcommittee about how drug shortages are hindering cancer care in the US and threatening the lives of patients.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...